眼黒色腫の世界市場レポート 2025年

眼黒色腫市場規模は、今後数年間で力強い成長が見込まれます。2029年には137億7,000万米ドルに成長し、CAGRは8.6%となります。予測期間の成長は、継続的な公衆衛生への取り組み、遺伝子および分子プロファイリングの調査、世界の高齢化動向に起因しています。予測期間における主な動向には、人工知能（AI）の統合、標的治療の出現、希少疾患治療薬開発への注力、患者中心の医薬品承認プロセス、画像診断の進歩、治療方法の進歩、画像診断の技術革新などがあります。

予測される眼がん患者の増加は、今後数年間の眼黒色腫市場拡大の重要な促進要因になると考えられます。眼がんは、眼球構造内の細胞の異常で制御不能な増殖を示します。発見技術の強化、認知度の向上、治療オプションの進歩により、初期の症例を効果的に管理するための専門的な治療や介入に対する需要が高まっています。例えば、米国がん協会の2023年1月の報告書によると、眼球および眼窩がんの症例は2023年には3,490件に増加し、2021年の3,320件から5.12%の伸びを示しました。したがって、眼球がん症例の急増が眼黒色腫市場の成長を促進すると予想されます。

高齢者人口の増加が予想されることから、眼黒色腫市場の拡大が当面見込まれます。眼球がんの一種である眼黒色腫は、高齢者が環境要因や遺伝的素因に長期間さらされることにより、加齢とともに流行する傾向があります。高齢者の人口増加により、眼黒色腫に罹患する可能性のある人の数は増加します。2022年10月に世界保健機関（WHO）が報告したように、60歳以上の人口は2021年の10億人から2022年には14億人に急増し、2050年には21億人に倍増すると予測されています。したがって、老年人口の増加が眼黒色腫市場の成長を牽引すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界眼黒色腫PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の眼黒色腫市場：成長率分析
• 世界の眼黒色腫市場の実績：規模と成長, 2019-2024
• 世界の眼黒色腫市場の予測：規模と成長, 2024-2029, 2034F
• 世界眼黒色腫総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の眼黒色腫市場：サイト別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブドウ膜
• 強膜
• 網膜
• 世界の眼黒色腫市場診断による、実績と予測, 2019-2024, 2024-2029F, 2034F
• イメージング
• 生検
• 眼科検診
• 世界の眼黒色腫市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手術
• 放射線治療
• 標的療法
• 免疫療法
• その他の治療
• 世界の眼黒色腫市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 学術機関
• 世界の眼黒色腫市場、ブドウ膜のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脈絡膜黒色腫
• 毛様体黒色腫
• 虹彩黒色腫
• 世界の眼黒色腫市場、強膜のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 強膜黒色腫
• 世界の眼黒色腫市場網膜のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 網膜黒色腫

第7章 地域別・国別分析

• 世界の眼黒色腫市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の眼黒色腫市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 眼黒色腫市場：競合情勢
• 眼黒色腫市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Novartis AG
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Sanofi S.A.
• GlaxoSmithKline PLC
• Eli Lilly and Company
• Amgen Inc.
• Koninklijke Philips N.V.
• Carl Zeiss AG
• Genentech Inc.
• Elekta Instrument AB
• Brainlab AG
• Optos Plc
• Castle Biosciences Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 眼黒色腫市場2029：新たな機会を提供する国
• 眼黒色腫市場2029：新たな機会を提供するセグメント
• 眼黒色腫市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Eye melanoma is a form of cancer that develops in the melanocytes, the cells responsible for producing melanin within the eye. This cancer can manifest in different parts of the eye, including the uvea, iris, and choroid. Eye melanoma stands as the most common primary intraocular cancer in adults and may lead to vision issues, alterations in eye color, and other symptoms, depending on its location and size.

The primary types of eye melanoma are found in the uvea, sclera, and retina. The uvea constitutes the middle layer of the eye, encompassing the iris, ciliary body, and choroid, housing blood vessels that supply nutrients to the eye. Various forms of radiation therapy, such as plaque brachytherapy, proton beam therapy, and stereotactic radiosurgery, are employed to target and reduce the size of uveal melanomas. Diagnosis involves imaging, biopsy, and eye examinations, while treatments include surgery, radiation therapy, targeted therapy, immunotherapy, and other approaches. These treatments are typically administered by end users such as hospitals, clinics, and academic institutes.

The eye melanoma market research report is one of a series of new reports from The Business Research Company that provides eye melanoma market statistics, including eye melanoma industry global market size, regional shares, competitors with an eye melanoma market share, detailed eye melanoma market segments, market trends and opportunities, and any further data you may need to thrive in the eye melanoma industry. This eye melanoma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The eye melanoma market size has grown strongly in recent years. It will grow from $9.1 billion in 2024 to $9.89 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased awareness and early detection, aging population and sun exposure, rise in skin cancer incidence, development of targeted therapies, patient advocacy and support programs.

The eye melanoma market size is expected to see strong growth in the next few years. It will grow to $13.77 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to continued public health initiatives, research in genetic and molecular profiling, global aging population trends. Major trends in the forecast period include integration of artificial intelligence (ai), emergence of targeted therapies, focus on rare disease drug development, patient-centric drug approval processes, advancements in diagnostic imaging, advancements in treatment modalities, technological innovations in imaging.

The projected rise in eye cancer cases is poised to be a significant driver for the eye melanoma market's expansion in the coming years. Eye cancer denotes the abnormal and uncontrolled growth of cells within the eye's structures. Enhanced detection techniques, increased awareness, and advancements in treatment options have led to a heightened demand for specialized therapies and interventions to effectively manage early cases. For example, according to the American Cancer Society's January 2023 report, eye and orbital cancer cases increased to 3,490 in 2023, marking a 5.12% growth from 3,320 in 2021. Therefore, the surge in eye cancer cases is expected to fuel the growth of the eye melanoma market.

The anticipated growth in the geriatric population is set to boost the eye melanoma market's expansion in the foreseeable future. Eye melanoma, a form of eye cancer, tends to become more prevalent with age due to prolonged exposure to environmental factors and genetic predispositions among older individuals. The expanding population of older adults increases the potential number of individuals susceptible to eye melanoma. As reported by the World Health Organization in October 2022, the population aged 60 and above surged from 1 billion in 2021 to 1.4 billion in 2022, with projections to double to 2.1 billion by 2050. Hence, the growing geriatric population is expected to drive the growth of the eye melanoma market.

Companies at the forefront of the eye melanoma treatment sector are dedicated to pioneering innovative and specialized treatments, particularly immunotherapies and targeted therapies, aiming to elevate patient outcomes and improve their quality of life. These novel treatment modalities have recently made significant strides in the field of oncology. For example, in January 2022, Immunocore Ltd., a UK-based biopharmaceutical firm specializing in soluble T-cell receptor technology for biological drug development, obtained approval from the U.S. Food and Drug Administration (FDA) for Kimmtrak (tebentafusp-tabn). This groundbreaking therapy, the first of its kind for individuals with unresectable or metastatic uveal melanoma (mUM), operates as an immunotherapy targeting the gp100 protein found on the surface of uveal melanoma cells. By activating the patient's immune system through engineered T-cell receptors, Kimmtrak enables a precision-focused approach to eliminating melanoma, leveraging specialized immune cells for cancer treatment.

In January 2023, Health Network One, a leading US-based specialty benefit management company, acquired Premier Eye Care for an undisclosed amount. This acquisition enables Health Network One to broaden its provider network, improve clinical quality, and foster innovation in ophthalmology services. Premier Eye Care, a US-based company, specializes in diagnosing and treating eye melanoma through various methods such as surgery, radiation, and laser therapy.

Major companies operating in the eye melanoma market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Koninklijke Philips N.V., Carl Zeiss AG, Genentech Inc., Elekta Instrument AB, Brainlab AG, Optos Plc, Castle Biosciences Inc., Heidelberg Engineering, Nektar Therapeutics, RaySearch Laboratories AB, Nidek Co. Ltd., IDEAYA Biosciences, Immunocore Limited, Topcon Healthcare, Oraya Therapeutics Inc., Delcath Systems Inc.

North America was the largest region in the eye melanoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye melanoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the eye melanoma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The eye melanoma market consists of revenues earned by entities by providing fine needle aspiration (FNA) techniques, blood testing, and genetic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The eye melanoma market also includes sales of drugs and therapeutics such as chemotherapy, cryotherapy, and photodynamic therapy (PDT). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Eye Melanoma Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on eye melanoma market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for eye melanoma ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The eye melanoma market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Site: Uvea; Sclera; Retina
• 2) By Diagnosis: Imaging; Biopsy; Eye Exam
• 3) By Treatment: Surgery; Radiation Therapy; Targeted Therapy; Immunotherapy; Other Treatment
• 4) By End User: Hospitals And Clinics; Academic Institutes
• Subsegments:
• 1) By Uvea: Choroid Melanoma; Ciliary Body Melanoma; Iris Melanoma
• 2) By Sclera: Scleral Melanoma
• 3) By Retina: Retinal Melanoma
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Merck & Co. Inc; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Eye Melanoma Market Characteristics

3. Eye Melanoma Market Trends And Strategies

4. Eye Melanoma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Eye Melanoma Growth Analysis And Strategic Analysis Framework

• 5.1. Global Eye Melanoma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Eye Melanoma Market Growth Rate Analysis
• 5.4. Global Eye Melanoma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Eye Melanoma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Eye Melanoma Total Addressable Market (TAM)

6. Eye Melanoma Market Segmentation

• 6.1. Global Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Uvea
• Sclera
• Retina
• 6.2. Global Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging
• Biopsy
• Eye Exam
• 6.3. Global Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Radiation Therapy
• Targeted Therapy
• Immunotherapy
• Other Treatment
• 6.4. Global Eye Melanoma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Academic Institutes
• 6.5. Global Eye Melanoma Market, Sub-Segmentation Of Uvea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Choroid Melanoma
• Ciliary Body Melanoma
• Iris Melanoma
• 6.6. Global Eye Melanoma Market, Sub-Segmentation Of Sclera, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Scleral Melanoma
• 6.7. Global Eye Melanoma Market, Sub-Segmentation Of Retina, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retinal Melanoma

7. Eye Melanoma Market Regional And Country Analysis

• 7.1. Global Eye Melanoma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Eye Melanoma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Eye Melanoma Market

• 8.1. Asia-Pacific Eye Melanoma Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Eye Melanoma Market

• 9.1. China Eye Melanoma Market Overview
• 9.2. China Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Eye Melanoma Market

• 10.1. India Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Eye Melanoma Market

• 11.1. Japan Eye Melanoma Market Overview
• 11.2. Japan Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Eye Melanoma Market

• 12.1. Australia Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Eye Melanoma Market

• 13.1. Indonesia Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Eye Melanoma Market

• 14.1. South Korea Eye Melanoma Market Overview
• 14.2. South Korea Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Eye Melanoma Market

• 15.1. Western Europe Eye Melanoma Market Overview
• 15.2. Western Europe Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Eye Melanoma Market

• 16.1. UK Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Eye Melanoma Market

• 17.1. Germany Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Eye Melanoma Market

• 18.1. France Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Eye Melanoma Market

• 19.1. Italy Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Eye Melanoma Market

• 20.1. Spain Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Eye Melanoma Market

• 21.1. Eastern Europe Eye Melanoma Market Overview
• 21.2. Eastern Europe Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Eye Melanoma Market

• 22.1. Russia Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Eye Melanoma Market

• 23.1. North America Eye Melanoma Market Overview
• 23.2. North America Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Eye Melanoma Market

• 24.1. USA Eye Melanoma Market Overview
• 24.2. USA Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Eye Melanoma Market

• 25.1. Canada Eye Melanoma Market Overview
• 25.2. Canada Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Eye Melanoma Market

• 26.1. South America Eye Melanoma Market Overview
• 26.2. South America Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Eye Melanoma Market

• 27.1. Brazil Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Eye Melanoma Market

• 28.1. Middle East Eye Melanoma Market Overview
• 28.2. Middle East Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Eye Melanoma Market

• 29.1. Africa Eye Melanoma Market Overview
• 29.2. Africa Eye Melanoma Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Eye Melanoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Eye Melanoma Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Eye Melanoma Market Competitive Landscape And Company Profiles

• 30.1. Eye Melanoma Market Competitive Landscape
• 30.2. Eye Melanoma Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Eye Melanoma Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Novartis AG
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. Sanofi S.A.
• 31.6. GlaxoSmithKline PLC
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. Koninklijke Philips N.V.
• 31.10. Carl Zeiss AG
• 31.11. Genentech Inc.
• 31.12. Elekta Instrument AB
• 31.13. Brainlab AG
• 31.14. Optos Plc
• 31.15. Castle Biosciences Inc.

32. Global Eye Melanoma Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Eye Melanoma Market

34. Recent Developments In The Eye Melanoma Market

35. Eye Melanoma Market High Potential Countries, Segments and Strategies

• 35.1 Eye Melanoma Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Eye Melanoma Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Eye Melanoma Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer